Literature DB >> 25817301

More similarities than differences between men and women with irritable bowel syndrome.

I Björkman1, E Jakobsson Ung2, G Ringström1, H Törnblom1, M Simrén1.   

Abstract

BACKGROUND: Differences regarding symptoms, coping abilities, and quality of life (QOL) between men and women with irritable bowel syndrome (IBS) have been reported but data are sparse and sometimes conflicting. The aim of present study was to investigate gender differences in gastrointestinal, extra-intestinal, and psychological symptoms, and sense of coherence (SOC) and QOL in a large group of patients diagnosed with IBS.
METHODS: We analyzed questionnaire data from 557 patients (152 men) diagnosed with IBS consecutively included in studies at an outpatient clinic for functional bowel disorders between 2002 and 2010. Following questionnaires were included: IBS severity scoring system (IBS-SSS), Hospital Anxiety and Depression Scale (HAD), IBSQOL Scale, Visceral Sensitivity Index (VSI), SOC Scale, Bristol Stool Form Scale (BSFS), and Patient Health Questionnaire (PHQ-15). KEY
RESULTS: Women had harder stools (FDR-adjusted p-value: q = 0.033), more severe bloating (q = 0.020), higher symptom severity (q = 0.042), higher total somatic symptom burden (q = 0.035), lower SOC (q = 0.042), and lower QOL. Women rated more general anxiety (q = 0.017) and gastrointestinal-specific anxiety (q = 0.042), but there were no group differences in depression, pain, stool frequency, impact on daily life, dissatisfaction with bowel habit, or extra-colonic symptoms. The differences found were small (effect sizes: r < 0.3). CONCLUSIONS & INFERENCES: In this study, we demonstrated more similarities than differences between men and women with IBS. The largest difference were seen for QOL which might reflect certain structural stressors to which women in general are more exposed than men.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  coping; gender differences; irritable bowel syndrome; quality of life; symptoms

Mesh:

Year:  2015        PMID: 25817301     DOI: 10.1111/nmo.12551

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  7 in total

1.  Childhood Irritable Bowel Syndrome Characteristics Are Related to Both Sex and Pubertal Development.

Authors:  Bruno P Chumpitazi; Erica M Weidler; Danita I Czyzewski; Mariella M Self; Margaret Heitkemper; Robert J Shulman
Journal:  J Pediatr       Date:  2016-09-14       Impact factor: 4.406

2.  Gender differences in irritable bowel syndrome: the interpersonal connection.

Authors:  E R Thakur; M B Gurtman; L Keefer; D M Brenner; J M Lackner
Journal:  Neurogastroenterol Motil       Date:  2015-08-12       Impact factor: 3.598

Review 3.  Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders.

Authors:  Susrutha Puthanmadhom Narayanan; Bradley Anderson; Adil E Bharucha
Journal:  Mayo Clin Proc       Date:  2021-04       Impact factor: 7.616

4.  The gut microbiota is a major regulator of androgen metabolism in intestinal contents.

Authors:  Hannah Colldén; Andreas Landin; Ville Wallenius; Erik Elebring; Lars Fändriks; Maria E Nilsson; Henrik Ryberg; Matti Poutanen; Klara Sjögren; Liesbeth Vandenput; Claes Ohlsson
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-11-05       Impact factor: 4.310

Review 5.  Extraintestinal manifestations in irritable bowel syndrome: A systematic review.

Authors:  Bodil Ohlsson
Journal:  Therap Adv Gastroenterol       Date:  2022-08-09       Impact factor: 4.802

6.  Quality of life and depression in patients with irritable bowel syndrome.

Authors:  Magdalena Kopczyńska; Łukasz Mokros; Tadeusz Pietras; Ewa Małecka-Panas
Journal:  Prz Gastroenterol       Date:  2018-05-16

7.  COVID-19 pandemic and lockdown stress consequences in people with and without Irritable Bowel Syndrome.

Authors:  J-M Sabate; D Deutsch; C Melchior; A Entremont; F Mion; M Bouchoucha; S Façon; J-J Raynaud; F Zerbib; P Jouët
Journal:  Ethics Med Public Health       Date:  2021-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.